感染疾病監測解決方案市場：按產品/服務、感染疾病類型、最終用戶和地區分類

Infection Surveillance Solutions Market, by Product and Services, by Infection Type by End User and By Geography

出版日期: 2026年04月01日 | 出版商:

Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，感染疾病監測解決方案市場規模將達到 10.204 億美元，到 2033 年將達到 26.168 億美元。預計從 2026 年到 2033 年，該市場將以 14.4% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	1,020,400,000 美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	14.40%	2033年市場規模預測：	26.168億美元

感染監測解決方案是一種軟體，可協助醫院和其他醫療機構向州和聯邦當局報告病患資料。感染監測解決方案在醫療產業中用於收集院內感染 (HAI) 的數據、調查感染模式並遏制感染向社區的傳播。院內感染是指感染從醫院和醫療機構傳播給其他人。該軟體透過在發生感染時向醫院的 IP 位址發送警報來預防集體爆發，使 HAI 專家和護理人員能夠及時治療感染患者。感染監測解決方案是支援醫療機構有效管理醫療相關感染 (HAI) 的程序。肺炎、胃腸道疾病、尿道感染感染、原發性血流感染疾病以及與某些手術相關的感染疾病是院內感染 (HAI) 的主要類型。院內感染 (HAI) 的高發生率是世界各國政府關注的主要問題，因此，各國政府正在製定政策以有效管理 HAI 並降低其發病率。

市場動態

預計在預測期內，市場主要參與者擴大採用非內部成長策略，例如透過收購來擴展產品系列，這將推動市場成長。例如，2019年5月，軟體公司RLDatix宣布收購iContracts，後者是一家為各行業提供基於雲端的合約、合規和收入管理軟體的公司。此次收購將RLDatix的病患安全平台與iContracts的尖端政策管理功能結合，使組織能夠首次透過動態的政策和程序執行來解決事件的根本原因。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球感染疾病監測解決方案市場的主要參與者進行了分析：公司亮點、產品系列、關鍵亮點、財務績效和策略。
本報告中的見解將使企業負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球感染疾病監測市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過各種用於分析全球感染疾病監測解決方案市場的策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

Baxter
BD
STERIS
Getinge AB
Medtronic
Koninklijke Philips NV
Abbott
Medexter Healthcare
Asolva
GOJO Industries, Inc.
Wolters Kluwer NV
VigiLanz Corporation
RLDatix
Roper Technologies, Inc.
Health Outcomes Worldwide
OpGen, Inc.
Urovant Sciences
Premier

第9章

調查方法
關於本公司

簡介目錄

Product Code: CMI1699

Infection Surveillance Solutions Market is estimated to be valued at USD 1020.4 Mn in 2026 and is expected to reach USD 2,616.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 14.4% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1020.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	14.40%	2033 Value Projection:	USD 2,616.8 Mn

Infection surveillance solution is software that helps healthcare facilities such as hospitals and others to report data related to patients, to the state and federal authorities. Infection surveillance solutions are used in the healthcare industry to collect data on nosocomial infections to study the pattern of infections and regulate their spread in the community. Nosocomial infections are infections that are spread to people from hospitals or healthcare centers. This software alerts hospital Internet Protocol (IPs) in case of infection occurrence so that HAI specialists and nurses can treat patients suffering from the infection in order to avoid outbreaks of infection. Infection surveillance solutions are programs, which help in the effective management of the Healthcare-Acquired Infections (HAIs) in healthcare facilities. Pneumonia, gastrointestinal illness, urinary tract infections, primary bloodstream infections, and infections related to some surgery are the few major Healthcare-Acquired Infections (HAIs). High incidences of Healthcare-Acquired Infections (HAIs) is a major concern for government across the globe, and hence, various governments have outlined policies to effectively manage and reduce incidences of HAIs.

Market Dynamics

Increasing adoption of inorganic growth strategies, such as acquisitions by key players in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in May 2019, RLDatix, a software company, announced that they had acquired iContracts, a provider of cloud-based contract, compliance, and revenue management software for multiple industries. The acquisition brings together the RLDatix patient safety platform with iContracts leading policy management capabilities to allow organizations, for the first time, to take action on the root causes of incidents through the implementation of policies and procedures that are dynamic.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global infection surveillance solutions market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study are Baxter, BD, STERIS, Getinge AB, Medtronic, Koninklijke Philips N.V., Abbott, Medexter Healthcare, Asolva, GOJO Industries, Inc., Wolters Kluwer N.V., VigiLanz Corporation, RLDatix, Roper Technologies Inc., Health Outcomes Worldwide, OpGen, Inc., Urovant Sciences, and Premier
Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global infection surveillance market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global infection surveillance solutions market

Market Segmentation

Global Infection Surveillance Solutions Market, By Products and Services (Revenue, USD Mn, 2021 - 2033)
Software
- On-Premises
- Web-Based
Services
- Support & Maintenance
- Training & Consulting
Global Infection Surveillance Solutions Market, By Infection Type (Revenue, USD Mn, 2021 - 2033)
Surgical Site Infections
Blood Stream Infections
Urinary Tract Infections
Global Infection Surveillance Solutions Market, By End User (Revenue, USD Mn, 2021 - 2033)
Hospitals
Clinics
Ambulatory Surgical Centers
Other (Specialty Center, etc.)
Global Infection Surveillance Market, By Region (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles
Baxter
BD
STERIS
Getinge AB
Medtronic
Koninklijke Philips N.V.
Abbott
Medexter Healthcare
Asolva
GOJO Industries, Inc.
Wolters Kluwer N.V.
VigiLanz Corporation
RLDatix
Roper Technologies, Inc.
Health Outcomes Worldwide
OpGen, Inc.
Urovant Sciences
Premier

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Products and Services
- Market Snapshot, By Infection Type
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Key Highlights
Product Launch
Technological Advancements
PEST Analysis
Regulatory Scenario
Mergers and Acquisitions

4. Global Infection Surveillance Solutions Market, By 2021 - 2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
  - On-Premises
  - Web-Based
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
  - Support & Maintenance
  - Training & Consulting

5. Global Infection Surveillance Solutions Market, By Infection Type, 2021 - 2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Surgical Site Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Blood Stream Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Urinary Tract Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

6. Global Infection Surveillance Solutions Market, By End User, 2021 - 2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segments Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Ambulatory Surgical Center
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Others (Specialty Center, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

7. Global Infection Surveillance Solutions Market, By Region, 2021 - 2033, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021 - 2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Million)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Baxter
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
BD
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
STERIS
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Getinge AB
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Medtronic
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Koninklijke Philips N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Medexter Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Asolva
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
GOJO Industries, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Wolters Kluwer N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
VigiLanz Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
RLDatix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Roper Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Health Outcomes Worldwide
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
OpGen, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Urovant Sciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Premier
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies